SYH2082 Injection

DRUG2 trials

Sponsors

CSPC ZhongQi Pharmaceutical Technology Co., Ltd., CSPC Ouyi Pharmaceutical Co., Ltd.

Conditions

Overweight or Obesity

Phase 1

A Single Ascending Dose Study of SYH2082 Injection in Healthy Participants

Not yet recruitingNCT07532655

CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Overweight or Obesity

Start: 2026-04-14End: 2027-02-09Target: 44Updated: 2026-04-16

A Study of SYH2082 Injection in Healthy Participants

Active, not recruitingNCT07736404

CSPC Ouyi Pharmaceutical Co., Ltd.Overweight or Obesity

Start: 2026-04-13End: 2026-12-30Updated: 2026-07-30